DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $676,820 | +480.3% | 2,728 | +461.3% | 0.14% | +466.7% |
Q2 2023 | $116,640 | -4.8% | 486 | 0.0% | 0.02% | -17.2% |
Q1 2023 | $122,491 | +8.1% | 486 | +13.8% | 0.03% | 0.0% |
Q4 2022 | $113,334 | +3.0% | 427 | 0.0% | 0.03% | -3.3% |
Q3 2022 | $110,000 | -35.7% | 427 | -36.8% | 0.03% | -43.4% |
Q2 2022 | $171,000 | -66.3% | 676 | -61.0% | 0.05% | -63.9% |
Q1 2022 | $508,000 | -10.9% | 1,733 | 0.0% | 0.15% | -4.5% |
Q4 2021 | $570,000 | -6.6% | 1,733 | -13.6% | 0.15% | -15.4% |
Q3 2021 | $610,000 | +13.4% | 2,005 | 0.0% | 0.18% | +11.7% |
Q2 2021 | $538,000 | +11.4% | 2,005 | -6.5% | 0.16% | -3.0% |
Q1 2021 | $483,000 | -2.6% | 2,145 | -3.9% | 0.17% | -8.2% |
Q4 2020 | $496,000 | +254.3% | 2,233 | +244.6% | 0.18% | +205.0% |
Q3 2020 | $140,000 | +21.7% | 648 | 0.0% | 0.06% | +13.2% |
Q2 2020 | $115,000 | +21.1% | 648 | -5.3% | 0.05% | 0.0% |
Q1 2020 | $95,000 | -4.0% | 684 | +5.6% | 0.05% | +12.8% |
Q4 2019 | $99,000 | +5.3% | 648 | 0.0% | 0.05% | -6.0% |
Q3 2019 | $94,000 | +9.3% | 648 | 0.0% | 0.05% | +4.2% |
Q2 2019 | $86,000 | 0.0% | 648 | 0.0% | 0.05% | 0.0% |
Q1 2019 | $86,000 | +28.4% | 648 | 0.0% | 0.05% | +11.6% |
Q4 2018 | $67,000 | -10.7% | 648 | -5.8% | 0.04% | 0.0% |
Q3 2018 | $75,000 | +10.3% | 688 | 0.0% | 0.04% | +4.9% |
Q2 2018 | $68,000 | +1.5% | 688 | 0.0% | 0.04% | +5.1% |
Q1 2018 | $67,000 | +4.7% | 688 | 0.0% | 0.04% | +5.4% |
Q4 2017 | $64,000 | – | 688 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |